Abbott Agrees to $384.9M Settlement; Hershey Appoints New CFO

Key Facts

1Abbott Laboratories agreed to pay $384,999,040 to resolve allegations concerning infant formula and nutritional therapy products.

2ServiceNow stock fell 3.20% to $131.28 alongside news of a successful EmployeeWorks platform deployment by a partner.

3The Hershey Company appointed Dave Hulays as CFO as its stock price saw a minor 0.60% decrease.

Abbott Laboratories agreed to pay $384,999,040 to resolve allegations concerning infant formula and nutritional therapy products, according to AD HOC NEWS. The settlement, announced by the U.S. Department of Justice, addresses claims involving products manufactured between 2018 and 2022, with the majority of the funds directed to the federal government. Separately, The Hershey Company appointed Dave Hulays as its new Chief Financial Officer, while ServiceNow stock fell 3.20% to $131.28.

ABT closed at $101.29 on September 25, 2026, and was later trading at $100.95 on September 28, 2026, following the settlement news. For Hershey, HSY closed at $166.37 on September 25, 2026, amid a minor 0.60% decrease linked to the executive transition. In the technology sector, NOW closed at $135.62 on September 25, 2026, despite reports of a partner's successful deployment of the EmployeeWorks platform.